ADVIA Centaur BNP Assay for in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur, Centaur XP, Centaur CP Systems; Catalog Numbers: Cat No. 02816138/SMN 10309044 (100 test) 02816634/SMN 10309045 (500 test)
Published November 26, 2014 · Recall initiated: October 6, 2014
Summary
FDA records medical device Class III recall Z-0229-2015, published November 26, 2014 and initiated October 6, 2014. Recalling firm: Siemens Healthcare Diagnostics, Inc; Status: Terminated; Reported quantity: 100 test - 4,600 kits; 500 test - 1,878 kits; Lot: Lot 038174: 100 Test - 43305174 and 43278174; 500 Test - 43306174 and 43279174. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Siemens Healthcare Diagnostics has confirmed that approximately 2000 ReadyPacks from the ADVIA Centaur® Systems BNP reagent contains an ADVIA Centaur Systems FT4 human-readable side label.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc
- Distributor
- Worldwide Distribution - US Nationwide including Puerto Rico; and countries of: Canada, Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Fren.Polynesia, Germany, Great Britain, Greece, Guadeloupe, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Reunion, Russian Fed., Slovakia, Slovenia, Spain, Switzerland, Turkey, Unit.Arab Emir., AR, AU, BR, CL, CN, CR, IN, JP, KR, LK, MY, SG, TW, UY, VN, and ZA.
- Lot
- Lot 038174: 100 Test - 43305174 and 43278174; 500 Test - 43306174 and 43279174.
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASiemens ADVIA Centaur Folate 100 test kit-for IVD of folate in serum or red blood cells SMN:10310308January 29, 2020
- FDASiemens Atellica IM aTG (100 test kit) Siemens Material Number (SMN): 10995461May 8, 2019
- FDAAtellica IM aTG (500 test kit) Siemens Material Number (SMN): 10995462May 8, 2019
- FDASiemensADVIA Centaur aTG (500 test kit) Siemens Material Number (SMN): 10492399May 8, 2019
- FDAFullFire Diffusing Tip Laser Probe, REF: DTP101-01, DTP201-01, DTP301-01, DTP401-01, DTP501-01. These laserNovember 26, 2014
- FDAEtest® Ceftaroline (CPT32) WW B30. Etest® (Antimicrobial Susceptibility Testing) is a quantitative techniqueNovember 26, 2014
Questions about this recall
Was ADVIA Centaur BNP Assay for in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur, Centaur XP, Centaur CP Systems; Catalog Numbers: Cat No. 02816138/SMN 10309044 (100 test) 02816634/SMN 10309045 (500 test) recalled?
Yes. FDA published recall Z-0229-2015 on November 26, 2014. Reported hazard: Siemens Healthcare Diagnostics has confirmed that approximately 2000 ReadyPacks from the ADVIA Centaur® Systems BNP reagent contains an ADVIA Centaur Systems FT4 human-readable side label.
What should I do if I have this product?
Voluntary: Firm initiated · Letter